CVS Health Stock Hands $31 Bil Back – Worth a Look?
In the last decade, CVS Health (CVS) stock has returned $31 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the market’s biggest capital-return machines.
As it turns out, CVS stock has returned the 90th highest amount to shareholders in history.
| CVS | S&P Median | |
|---|---|---|
| Dividends | $10 Bil | $4.5 Bil |
| Share Repurchase | $20 Bil | $5.5 Bil |
| Total Returned | $31 Bil | $9.1 Bil |
| Total Returned as % of Current Market Cap | 29.9% | 25.3% |
Why should you care? Because dividends and share repurchases represent direct, tangible returns of capital to shareholders. They also signal management’s confidence in the company’s financial health and ability to generate sustainable cash flows. And there are more stocks like that. Here is a list of the top 10 companies ranked by total capital returned to shareholders via dividends and stock repurchases.
Single stock can be risky, but there is a huge value to a broader diversified approach. Strategic asset allocation and diversification helps you stay invested. Did you know investors who panicked out of the S&P in 2020 lost significant upside that followed? Trefis High Quality Portfolio and Empirical Asset Management’s asset allocation approach are designed to reduce volatility so you can stay the course.
Top 10 Stocks By Total Shareholder Return
| Total Money Returned | As % Of Current Market Cap | via Dividends | via Share Repurchases | |
|---|---|---|---|---|
| AAPL | $847 Bil | 21.9% | $141 Bil | $706 Bil |
| MSFT | $364 Bil | 9.4% | $165 Bil | $199 Bil |
| GOOGL | $343 Bil | 11.2% | $12 Bil | $331 Bil |
| XOM | $212 Bil | 42.2% | $145 Bil | $67 Bil |
| WFC | $208 Bil | 76.2% | $59 Bil | $150 Bil |
| JPM | $174 Bil | 21.2% | $0.0 | $174 Bil |
| META | $167 Bil | 9.0% | $6.4 Bil | $160 Bil |
| ORCL | $161 Bil | 20.3% | $34 Bil | $126 Bil |
| JNJ | $157 Bil | 33.8% | $104 Bil | $52 Bil |
| CVX | $153 Bil | 56.7% | $97 Bil | $55 Bil |
For full ranking, visit Buybacks & Dividends Ranking
What do you notice here? The total capital returned to shareholders as a % of the current market cap appears inversely proportional to growth prospects for reinvestments. Stocks like Meta (META) and Microsoft (MSFT) are growing much faster, in a more predictable way, compared to the others, but they have returned a much lower fraction of their market cap to shareholders.
That’s the flip side to high capital returns. Sure, they are attractive, but you have to ask yourself the question: Am I sacrificing growth and sound fundamentals? With that in mind, let’s look at some numbers for CVS. (see Buy or Sell CVS Health Stock for more details)
CVS Health Fundamentals
- Revenue Growth: 5.0% LTM and 8.1% last 3-year average.
- Cash Generation: Nearly 1.6% free cash flow margin and 2.9% operating margin LTM.
- Recent Revenue Shocks: The minimum annual revenue growth in the last 3 years for CVS was 5.0%.
- Valuation: CVS Health stock trades at a P/E multiple of 19.4
- Opportunity vs S&P: Compared to S&P, you get lower valuation, higher 3 year average revenue growth, and lower margins
| CVS | S&P Median | |
|---|---|---|
| Sector | Health Care | – |
| Industry | Health Care Services | – |
| PE Ratio | 19.4 | 24.1 |
|
|
||
| LTM* Revenue Growth | 5.0% | 5.2% |
| 3Y Average Annual Revenue Growth | 8.1% | 5.3% |
| Min Annual Revenue Growth Last 3Y | 5.0% | -0.1% |
|
|
||
| LTM* Operating Margin | 2.9% | 18.7% |
| 3Y Average Operating Margin | 3.8% | 17.8% |
| LTM* Free Cash Flow Margin | 1.6% | 13.3% |
*LTM: Last Twelve Months
That’s a good overview, but evaluating a stock from an investment perspective involves much more. That is exactly what Trefis High Quality Portfolio does. It is designed to reduce stock-specific risk while giving upside exposure.
CVS Historical Risk
That said, CVS isn’t immune to big drops. It plunged over 62% in the Dot-Com Bubble and lost about 45% during the Global Financial Crisis. Even the smaller pullbacks, like the 2018 correction and inflation shock, saw dips close to 35-40%. The Covid selloff wasn’t painless either, with a roughly 30% drop. Solid fundamentals matter, but when volatility hits, CVS can still take serious hits.
But the risk is not limited to major market crashes. Stocks fall even when markets are good – think events like earnings, business updates, and outlook changes. Read CVS Dip Buyer Analyses to see how the stock has recovered from sharp dips in the past.
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.